EGFR and non-small cell lung carcinoma: In the present study, we evaluated the ability of the immuno-wall device to specifically detect mutated EGFR proteins in surgically resected tissues from NSCLC patients and successfully performed rapid mutant EGFR detection in a small volume (1 μL) of lysed, debris-rich, surgically resected samples without the need for thorough pretreatments.